Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

OVA peptides

CATALOG PEPTIDES OVA Variants & others OVA-A2 Peptide, SAINFEKL, OVA (257-264) Variant OVA-G4 Peptide, SIIGFEKL, OVA (257-264) Variant OVA-Q4 Peptide, pQ4, SIIQFEKL, OVA (257-264) Variant OVA-T4 Peptide, SIITFEKL, pT4, OVA (257-264) Variant OVA-Q4H7 Peptide, S

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

OVA is a model antigen extensively studied

Proteolytic processing of proteins in the cytoplasm generates peptide epitopes that are generally 8-10 amino acids in length. The binding of these peptides to the surface major histocompatibility complex (MHC) class I molecules and subsequent presentation to T-cells elicits an immune response.1

A model antigen extensively studied is Ovalbumin (OVA). OVA is processed to the presenting octapeptide (257-264), SIINFEKL, through proteasomal and non-proteasomal activities.2 As with peptides naturally presented by H-2Kb, SIINFEKL has on its 5th position an amino acid with an aromatic side chain (Phe) and on the 8th position, an aliphatic side chain (Leu).3 Variants of this peptide consisting of substituting different amino acids at strategic positions have yielded valuable information on the interaction of this peptide and the MHC complex.3


References
1. Heemel, M & H. Ploegh Annu. Rev. Biochem. 64, 463 (1995).
2. Beninga, J. et al. J. Biol. Chem. 273, 18734 (1998).
3. Hin, S. et al. J. Biol. Chem. 276, 48790 (2001).

P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →